Previous Article | Next Article 
Journal of Clinical Microbiology, April 2004, p. 1648-1651, Vol. 42, No. 4
0095-1137/04/$08.00+0 DOI: 10.1128/JCM.42.4.1648-1651.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Analysis of Helicobacter pylori Genotypes and Correlation with Clinical Outcome in Turkey
Huseyin Saribasak,1 Barik A. Salih,1* Yoshio Yamaoka,2 and Ersan Sander3
Fatih University, Faculty of Science, Department of Biology/Microbiology Unit,1
Department of Gastroenterology, SSK Samatya Hospital Istanbul, Turkey,3
Department of Medicine, Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas 770302
Received 12 December 2003/
Returned for modification 23 December 2003/
Accepted 21 January 2004

ABSTRACT
The predominant
Helicobacter pylori strains circulating among
geographic locations differ in regard to genomic structure.
The association of the
cagA-positive,
vacA s1 genotypes with
peptic ulcer disease (PUD) and gastric cancer was reported in
Western countries but not in East Asian countries. Strains from
Western countries predominantly possessed
cagA type 2a,
vacA s1a or s1b/m1a, or
vacA m2a genotypes, whereas strains from
East Asia possessed
cagA type 1a,
vacA s1c/m1b, or
vacA m2b
genotypes. Whether the Turkish strains possessed such genotypes
was investigated and correlated with the disease outcome. Seventy-three
patients from Turkey were enrolled.
H. pylori was detected in
65 (89%) patients (22 with gastritis, 33 with PUD, and 10 with
gastric cancer) by any of the following tests:
Campylobacter-like
organism test, culture, or PCR. Among the
H. pylori-positive
patients, presence of the
cagA gene (78%) was significantly
associated with PUD (
P < 0.00001), gastric cancer (
P <
0.001), and
vacA s1a genotypes (
P < 0.0001). Multiple
vacA genotypes were more prevalent in PUD and gastric cancer patients
than in patients with gastritis. Restriction fragment length
polymorphism analysis of the
cagA gene revealed three different
patterns with no significant association with clinical outcome.
Turkish strains examined predominantly possessed
cagA type 2a,
vacA s1a/m1a, or
vacA m2a genotypes, which were typical genotypes
in strains from Western countries. This fact might be one of
the reasons for the low prevalence of severe gastroduodenal
diseases in Turkey compared to the East Asian countries.

INTRODUCTION
The
Helicobacter pylori genotypes and the geographic distribution
are linked to the severity of peptic ulcer disease (PUD) (
9,
13,
27).
H. pylori appears to be one of the most genetically
diverse bacterial species, as evidenced by the presence, among
different strains, of nonconserved DNA fragments such as the
cagA gene in the
cag pathogenicity island and allelic variation
within the
vacA gene (
9,
27,
31). Such diversity was found to
affect the function and antigenicity of virulence factors associated
with bacterial infection and, ultimately, disease outcome (
6,
14,
31).
The cagA gene, located at the right end of the cag pathogenicity island that contains approximately 30 genes, encodes the CagA protein, which varies in molecular mass between 120 and 140 kDa (8, 30). The vacA gene, which encodes the vacuolating cytotoxin, is the major toxin secreted by H. pylori that induces vacuolation in the human epithelial cells in vitro (3, 10, 23). Previous studies permitted a comprehensive description of the vacA signal (s) and middle (m) regions, which exist as s1 or s2 and m1 or m2, respectively (3). In Western countries, the presence of vacA s1 and cagA was reported to be significantly associated with PUD (4, 25, 28), whereas such association has not been reported in Asian countries (21, 31).
This discrepancy between Western countries and Asia might be explained by the fact that the predominant H. pylori strain circulating among geographic locations differs with regard to the genomic structure. The variation of the cagA gene was attributed to the presence of a variable number of repeated sequences in the 3' region of the gene (8, 22, 30, 32). We previously reported that the sequence of the 3' region of the cagA gene from isolates in East Asia (type 1a) differs markedly from the primary sequence of cagA genes from isolates in Western countries (type 2a) (30, 33). The vacA s1 region was subtyped into s1a, s1b, and s1c; the m1 region was subtyped into m1a, m1b, and m1c; and the m2 region was subtyped into m2a and m2b (4, 14, 20, 21, 25, 27, 28, 31). Previous studies showed that the vacA s1a or s1b genotypes were predominant in strains from Western countries, whereas s1c is highly prevalent in strains from East Asia (28, 33). The vacA m1a and m2a genotypes were predominant in strains from Western countries, the m1c genotype was predominant in strains from South Asia, and the m1b and m2b genotypes were predominant in strains from East Asia (28, 33). Overall, strains from Western countries predominantly possessed cagA type 2a; vacA s1a, s1b, or s2/m1a; or m2a genotypes. Strains from South Asia predominantly possessed cagA type 2a and vacA s1a/m1c genotypes, whereas strains from East Asia predominantly possessed cagA type 1a, vacA s1c/m1b, or m2b genotypes (28, 33). These variations in the global distribution of the cagA and vacA genotypes may reflect the diversity of reports associating the cagA and vacA genotypes with the clinical outcome from different geographic regions.
Turkey's geographic location, which has been under continuous influences from both Asian and Western countries, has made it an ideal site for epidemiological studies on H. pylori infection and genotyping. The prevalence of gastric cancer in Turkey is much lower than that in certain Asian countries (e.g., Japan) according to the World Health Organization world cancer report (29a) (annual rates of 4,440 cases [Turkey] versus 115,294 cases [Japan]/100,000 individuals); however, it is not known whether the difference is due to host, environment, or bacterial factors or a combination of these factors. Since no detailed studies in Turkey on the distribution and association of H. pylori cagA and vacA genotypes with PUD have been reported, our objectives were to detect whether the cagA and vacA genotypes of the Turkish strains were of the genotypes typically observed in Western countries or in Asia and to determine their association with clinical outcomes.

MATERIALS AND METHODS
Patients.
Seventy-three patients (42 males, 31 females; mean age, 46 years;
age range, 17 to 80 years) (22 with gastritis, 33 with PUD,
and 10 with gastric cancer) were enrolled in this study. Three
biopsy specimensfor
Campylobacter-like organism (CLO)
test, culture, and PCRwere taken from the antral part
of the stomach of each patient. Gastritis patients had chronic
histological gastritis without peptic ulcer, gastric cancer,
or esophageal disease. Peptic ulcers were defined endoscopically.
Gastric cancer patients had no other primary malignancies or
inflammatory diseases. Patients had received no treatment for
H. pylori infection. Informed consent was obtained from all
patients and approved by an ethics committee at Fatih University.
Culture.
Biopsy specimens placed in 1 ml of normal saline (0.9% sodium chloride) were dissected and spread on Columbia agar plates containing 5% horse blood and then were incubated under microaerobic conditions in an anaerobic jar at 37°C for 5 to 7 days. The organisms were identified as H. pylori by colony morphology; Gram stain reaction; and positive reactions to oxidase, catalase, and urease activities. Cultures were harvested and stored in nutrient broth containing 20% glycerol at 80°C.
DNA isolation and PCR.
DNA isolation was done using the QIAamp DNA kit (Qiagen Co., Hilden, Germany) according to the manufacturer's instructions. The presence of the cagA gene as well as the cagA genotype (type 1a, specific genotype in strains from East Asia, versus type 2a, typically observed in strains from Western countries) was performed as previously described (23, 32, 33). The vacA genotypes (s1a, s1b, s1c, m1a, m1b, m1c, m2a, and m2b) were identified as previously described (3, 28, 31, 33). Amplified PCR products were visualized by electrophoresis on 2% agarose gels, and imaging and analysis of bands were done using Gel Doc 2000 (Bio-Rad, Milan, Italy).
RFLP analysis.
The restriction fragment length polymorphism (RFLP) analysis procedure described earlier (7) was followed. A 10-µl sample of the PCR product of the cagA gene was digested with 10 U of the restriction enzyme HaeIII (Sigma, St. Louis, Mo.) for 4 h at 37°C as recommended by the supplier. The digested fragments were then electrophoresed on 2% agarose gel.
Statistical analysis.
The chi-square test with Yates correction was used. The P value set at <0.05 was regarded as statistically significant.

RESULTS
Patients were considered infected with
H. pylori when the gastric
biopsy specimens gave positive results in any one of the objective
tests: CLO test, culture, or PCR. Sixty-five (89%) of 73 patients
were
H. pylori positive. Among these, 49 (75%) were positive
by the CLO test, 48 (74%) were positive by culture, and 65 (100%)
were positive by PCR. PCR amplification of DNA sample directly
from gastric biopsy specimens detected the
cagA gene in 51 (78%)
of 65 patients, including 12 (55%) of 22 patents with gastritis,
5 (100%) of 5 patients with gastric ulcer, 25 (89%) of 28 patients
with duodenal ulcer, and 9 (90%) of 10 patients with gastric
cancer (Table
1). All
cagA genotypes detected were type 2a,
which was typically observed in strains from Western countries
and showed a significant association with PUD (
P < 0.00001)
and gastric cancer (
P < 0.001). PCR amplification of DNA
samples isolated from culture material (single colony or pool
of colonies) gave similar results to the DNA isolated directly
from gastric biopsy specimens.
The
vacA s1a genotype was detected in 54 (83%) of 65 patients:
18 (82%) of 22 with gastritis, 5 (100%) of 5 with gastric ulcer,
23 (82%) of 28 with duodenal ulcer, and 8 (80%) of 10 with gastric
cancer (Table
2). The
vacA s1a genotype had no significant association
with PUD. No other
vacA s1 subtype was detected in this study
except for one s1b subtype in a patient with gastritis. The
vacA s2 genotype was found in three (5%) of the patients. The
vacA m1 genotype was detected in 8 (12%) patients, while the
m2 genotype was detected in 28 (43%) of the 65 patients. All
m1 genotypes were m1a genotype, and those of the m2 genotype
were m2a genotype (Table
2). Both genotypes have been thought
to be specific to strains from Western countries. Table
1 shows
the association between the
cagA and
vacA s1a expression and
PUD. The expression of the
cagA gene was strongly associated
with that of the
vacA s1a genotype (
P < 0.0001) in patients
with gastric ulcer, duodenal ulcer, and gastric cancer. No significant
association was found between
cagA and
vacA m1 or m2 genotypes
and PUD. Multiple
vacA genotypes were significantly more prevalent
in PUD and gastric cancer patients than in patients with gastritis
(Table
2).
PCR-RFLP analysis performed on specimens from 30 randomly selected
subjects revealed three different patterns following digestion
of the amplified
cagA gene with the HaeIII enzyme (Table
3).
These patterns had no significant association with clinical
outcomes.

DISCUSSION
The geographic distribution of distinct
H. pylori genotypes
remains largely unknown, and the prevalence of virulent bacterial
genotypes in certain regions, particularly in Western countries,
may have important epidemiological consequences that are linked
to the presence of the
cagA gene and the severity of
H. pylori-related
diseases (
4,
9,
25,
27,
28). In Europe
cagA-positive
H. pylori is reported to account for 60 to 70% of
H. pylori strains (
1,
5,
23), while reports from East Asian countries have shown that
more than 90% of
H. pylori strains are
cagA positive irrespective
of the disease presentation (
16,
18). Such differences in the
prevalence of
cagA positivity could not be explained precisely;
however, they have been attributed to the genetic heterogeneity
or to differences in the geographic locations (
9,
32,
33). The
present study revealed that the majority of PUD and gastric
cancer patients were infected with
cagA-positive strains as
opposed to gastritis patients. These findings further substantiate
the role of
cagA as a marker for increased virulence and are
in agreement with studies from Western countries (
2,
24). More
importantly, all
cagA genotypes detected were type 2a, which
was typically observed in strains from Western countries.
Analysis of H. pylori isolates from diverse geographic locations also showed high variability in the vacA gene (25, 28, 33). The vacA s1a and m2a genotypes predominant in our strains were also predominant in strains from Western countries. In the present study, the cagA-positive status was strongly associated with vacA s1a and PUD, which is in agreement with previous reports from Western countries (25, 28). In contrast, such relationships were not reported in studies from East Asia (16, 31). Overall, we may be able to conclude that only the cagA type 2a and vacA s1a genotypes typically observed in strains from Western countries, but not in strains from East Asia, are related to the clinical outcomes. Recently, Higashi et al. (15) have shown that the East Asia-specific CagA sequences (type 1a) conferred stronger Src homology-2 binding and morphological transforming activities to Western type CagA sequences (type 2a) and concluded that the presence of distinctly structured CagA proteins in Western and Asian H. pylori strains might underlie the striking differences in the incidence of gastric carcinoma between these two geographic regions. Thus, the cagA type 1a and vacA s1c genotypes typically observed in strains from East Asia might be the most virulent strains, followed by the cagA type 2a and vacA s1a genotypes observed in strains from Western countries, while the cagA-negative and vacA s2 genotypes are considered the least virulent strains. In this study, our findings that no Turkish strains examined possessed cagA type 1a and vacA s1c genotypes might be one of the reasons for the low prevalence of gastric cancer in Turkey.
Since it has been demonstrated that H. pylori carries only a single copy of the vacA gene, detection of multiple genotypes implies the presence of multiple strains in a clinical sample (27). The risk of coinfection or superinfection with multiple strains may be higher in countries with a high prevalence of H. pylori infection than in those with a low prevalence (11, 19, 27). Multiple vacA genotypes detected in this study were more prevalent in patients with PUD than in those with gastritis, which is in agreement with a study done by Gonzales-Valencia et al. (12), but not with that of Wang et al. (29). Further studies will be necessary to examine whether infection with multiple strains increases the risk of serious clinical outcomes or not.
Discrimination between closely related isolates of H. pylori is needed for epidemiological and clinical purposes and precise methods of strain characterization are necessary to monitor H. pylori infections. PCR-RFLP analysis has been widely used for H. pylori typing (17, 26). Li et al. (17) reported that RFLP analysis was a reliable method to detect multiple strains and suggested that it might be useful as a primary approach for the identification of specific H. pylori strains; however, we found no association between the RFLP pattern and PUD in the present study.
In conclusion, all Turkish strains examined possessed cagA/vacA genotypes typically observed in strains from Western countries. This finding might be one of the reasons for the low prevalence of severe gastroduodenal diseases such as gastric cancer in Turkey. The presence of the cagA gene was significantly associated with that of the vacA s1a genotype and the clinical presentations of PUD and gastric cancer. Multiple vacA genotypes were more prevalent in patients with PUD and gastric cancer than in those with gastritis.

FOOTNOTES
* Corresponding author. Mailing address: Department of Biology/Microbiology Unit, Faculty of Science, Fatih University, B. cekmece, Istanbul, Turkey. Phone: 90 212 889 0810, ext. 1041. Fax: 90 212 889 0832. E-mail:
basalih{at}fatih.edu.tr.


REFERENCES
1 - Andreson, H., K. Lõivukene, T. Sillakivi, H.-I. Maaroos, M. Ustav, A. Peetsalu, and M. Mikelsaar. 2002. Association of cagA and vacA genotypes of Helicobacter pylori with gastric diseases in Estonia. J. Clin. Microbiol. 40:298-300.[Abstract/Free Full Text]
2 - Arents, N. L., A. A. van Zwet, J. C. Thijs, A. M. Kooistra-Smid, K. R. van Slochteren, J. E. Degener, J. H. Kleibeuker, and L. J. van Doorn. 2001. The importance of vacA, cagA, and iceA genotypes of Helicobacter pylori infection in peptic ulcer disease and gastroesophageal reflux disease. Am. J. Gastroenterol. 96:2603-2608.[CrossRef][Medline]
3 - Atherton, J. C., P. Cao, R. M. Peek, Jr., M. K. Tumurru, M. J. Blaser, and T. L. Cover. 1995. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori: association of specific vacA types with cytotoxin production and peptic ulceration. J. Biol. Chem. 270:17771-17777.[Abstract/Free Full Text]
4 - Atherton, J. C., P. Cao, R. M. Pekk, M. K. R. Tummuru, M. J. Blaser, and T. L. Cover. 1997. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 112:92-99.[CrossRef][Medline]
5 - Audibert, C., C. Burucoa, B. Janvier, and J. L. Fauchere. 2001. Implication of the structure of the Helicobacter pylori cag pathogenicity island in induction of interleukin-8 secretion. Infect. Immun. 69:1625-1629.[Abstract/Free Full Text]
6 - Blaser, M. J., and D. E. Berg. 2001. Helicobacter pylori genetic diversity and risk of human disease. J. Clin. Investig. 107:767-773.[Medline]
7 - Burucoa, C., V. Lhomne, and J. L. Fauchere. 1999. Performance criteria of DNA fingerprinting methods for typing of Helicobacter pylori isolates: experimental results and meta-analysis. J. Clin. Microbiol. 37:4071-4080.[Abstract/Free Full Text]
8 - Covacci, A., S. Censini, M. Bugnoli, R. Petracca, D. Burroni, G. Macchia, A. Massone, E. Papini, Z. Xiang, N. Figura, and R. Rappuoli. 1993. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc. Natl. Acad. Sci. USA 90:5791-5795.[Abstract/Free Full Text]
9 - Covacci, A., J. L. Telford, G. D. Giudice, J. Parsonnet, and R. Rappouoli. 1999. Helicobacter pylori virulence and genetic geography. Science 284:1328-1333.[Abstract/Free Full Text]
10 - Cover, T. L., C. P. Dooley, and M. J. Blaser. 1990. Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolating cytotoxin activity. Infect. Immun. 58:603-610.[Abstract/Free Full Text]
11 - De Gusmão, V. R., E. N. Mendes, D. M. De Magalhães Queiroz, G. A. Rocha, A. M. C. Rocha, A. A. R. Ashour, and A. S. T. Carvalho. 2000. vacA genotypes in Helicobacter pylori strains isolated from children with and without duodenal ulcer in Brazil. J. Clin. Microbiol. 38:2853-2857.[Abstract/Free Full Text]
12 - Gonzales-Valencia, G., J. C. Atherton, O. Munoz, M. Dehesa, A. Madrazo-de la Garza, and J. Torres. 2000. Helicobacter pylori vacA and cagA genotypes in Mexican adults and children. J. Infect. Dis. 182:1450-1454.[CrossRef][Medline]
13 - Graham, D. Y. 1997. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology 113:1983-1991.[CrossRef][Medline]
14 - Han, S. R., H. J. Schreiber, S. Bhakdi, M. Loos, and M. J. Maeurer. 1998. vacA genotypes and genetic diversity in clinical isolates of Helicobacter pylori. Clin. Diagn. Lab. Immunol. 5:139-145.[Abstract/Free Full Text]
15 - Higashi, H., R. Tsutsumi, A. Fujita, S. Yamazaki, M. Asaka, T. Azuma, and M. Hatakeyama. 2002. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc. Natl. Acad. Sci. USA 99:14428-14433.[Abstract/Free Full Text]
16 - lto, Y., T. Azuma, S. lto, H. Miyaji, M. Hirai, Y. Yamazaki, F. Sato, T. Kato, Y. Kohli, and M. Kuriyama. 1997. Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan. J. Clin. Microbiol. 35:1710-1714.[Abstract]
17 - Li, C., T. Ha, D. S. Chi, D. A. Ferguson, Jr., C. Jiang, J. J. Laffan, and E. Thomas. 1997. Differentiation of Helicobacter pylori strains directly from gastric biopsy specimens by PCR-based restriction fragment length polymorphism analysis without culture. J. Clin. Microbiol. 35:3021-3025.[Abstract]
18 - Maeda, S., K. Ogura, H. Yoshida, F. Kanai, T. Ikenoue, N. Kato, Y. Shiratori, and M. Omata. 1998. Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan. Gut 42:338-343.[Abstract/Free Full Text]
19 - Morales-Espinosa, R., G. Castillo-Rojas, G. Gonzalez-Valencia, S. P. De Leon, A. Cravioto, J. C. Atherton, and Y. L. Vidal. 1999. Colonization of Mexican patients by multiple Helicobacter pylori strains with different vacA and cagA genotypes. J. Clin. Microbiol. 37:3001-3004.[Abstract/Free Full Text]
20 - Mukhopadhyay, A. K., D. Kersulyte, J. Y. Jeong, S. Datta, Y. Ito, A. Chowdhury, S. Chowdhury, A. Santra, S. K. Bhattacharya, T. Azuma, G. B. Nair, and D. E. Berg. 2000. Distinctiveness of genotypes of Helicobacter pylori in Calcutta, India. J. Bacteriol. 182:3219-3227.[Abstract/Free Full Text]
21 - Pan, Z. J., D. E. Berg, R. W. van de Hulst, W. W. Su, A. Raudonikiene, S. D. Xiao, J. Dankert, G. N. J. Tytgat, and A. van der Ende. 1998. Prevalence of vacuolating cytotoxin production and distribution of distinct vacA alleles in Helicobacter pylori from China. J. Infect. Dis. 178:220-226.[Medline]
22 - Rota, C. A., J. C. Pereira-Lima, C. Blaya, and N. B. Nardi. 2001. Consensus and variable region PCR analysis of Helicobacter pylori 3' region of cagA gene in isolates from individuals with or without peptic ulcer. J. Clin. Microbiol. 39:606-612.[Abstract/Free Full Text]
23 - Rudi, J., C. Kolb, M. Maiwald, D. Kuck, A. Sieg, P. R. Galle, and W. Stremmel. 1998. Diversity of Helicobacter pylori vacA and cagA genes and relationship to VacA and CagA protein expression, cytotoxin production, and associated diseases. J. Clin. Microbiol. 36:944-948.[Abstract/Free Full Text]
24 - Stephens, J. C., J. A. Stewart, A. M. Folwell, and B. J. Rathbone. 1998. Helicobacter pylori cagA status, vacA genotypes and ulcer disease. Eur. J. Gastroenterol. Hepatol. 10:381-384.[Medline]
25 - Strobel, S., S. Bereswill, P. Balig, P. Allgaier, H. G. Sonntag, and M. Kist. 1998. Identification and analysis of a new vacA genotype variant of Helicobacter pylori in different patient groups in Germany. J. Clin. Microbiol. 36:1285-1289.[Abstract/Free Full Text]
26 - Tanahashi, T., M. Kita, T. Kodama, N. Sawai, Y. Yamaoka, S. Mitsufuji, F. Katoh, and J. Imanishi. 2000. Comparison of PCR-restriction fragment length polymoprphism analysis and PCR-direct sequencing methods for differentiating Helicobacter pylori ureB gene variants. J. Clin. Microbiol. 38:165-169.[Abstract/Free Full Text]
27 - van Doorn, L., J., C. Figueiredo, R. Rossau, G. Jannes, M. V. Asbroeck, J. C. Sousa, F. Carneiro, and W. G. V. Quint. 1998. Typing of Helicobacter pylori vacA gene and detection of cagA gene by PCR and reverse hybridization. J. Clin. Microbiol. 36:1271-1276.[Abstract/Free Full Text]
28 - van Doorn, L., J., C. Figueiredo,. F. Megraud, A. S. Pena, P. Midolo, D. M. Queiroz, F. Carneiro, B. Vanderborght, M. G. J. Pegado, R. Sanna, W. de Boer, P. M. Schneeberger, P. Correa, E. K. W. Ng, J. C. Atherton, M. J. Blaser, and W. G. V. Quint. 1999. Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology 116:823-830.[CrossRef][Medline]
29 - Wang, J., L. J. van Doorn, P. A. Robinson, X. Ji, D. Wang, Y. Wang, L. Ge, J. L. Telford, and J. E. Crabtree. 2003. Regional variation among vacA alleles of Helicobacter pylori in China. J. Clin. Microbiol. 41:1942-1945.[Abstract/Free Full Text]
29 - World Health Organization. 2003. World cancer report. International Agency for Research on Cancer, Geneva, Switzerland.
30 - Yamaoka, Y., T. Kodama, K. Kashima, D. Y. Graham, and A. R. Sepulveda. 1998. Variants of the 3' region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J. Clin. Microbiol. 36:2258-2263.[Abstract/Free Full Text]
31 - Yamaoka, Y., T. Kodama, O. Gutierrez, J. G. Kim, K. Kashima, and D. Y. Graham. 1999. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J. Clin. Microbiol. 37:2274-2279.[Abstract/Free Full Text]
32 - Yamaoka, Y., H. M. El-Zimaity, O. Gutierrez, N. Figura, J. G. Kim, T. Kodama, K. Kashima, D. Y. Graham, and J. K. Kim. 1999. Relationship between the cagA 3' repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology 117:342-349.[CrossRef][Medline]
33 - Yamaoka, Y., E. Orito, M. Mizokami, O. Gutierrez, N. Saitou, T. Kodama, M. S. Osato, J. G. Kim, F. C. Ramirez, V. Mahachai, and D. Y. Graham. 2002. Helicobacter pylori in North and South America before Columbus. FEBS Lett. 517:180-184.[CrossRef][Medline]
Journal of Clinical Microbiology, April 2004, p. 1648-1651, Vol. 42, No. 4
0095-1137/04/$08.00+0 DOI: 10.1128/JCM.42.4.1648-1651.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Nguyen, L. T., Uchida, T., Murakami, K., Fujioka, T., Moriyama, M.
(2008). Helicobacter pylori virulence and the diversity of gastric cancer in Asia. J Med Microbiol
57: 1445-1453
[Abstract]
[Full Text]
-
Hussein, N. R., Mohammadi, M., Talebkhan, Y., Doraghi, M., Letley, D. P., Muhammad, M. K., Argent, R. H., Atherton, J. C.
(2008). Differences in Virulence Markers between Helicobacter pylori Strains from Iraq and Those from Iran: Potential Importance of Regional Differences in H. pylori-Associated Disease. J. Clin. Microbiol.
46: 1774-1779
[Abstract]
[Full Text]